• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与接受tPA治疗的中风患者的良好预后有关吗?

Is smoking associated with favourable outcome in tPA-treated stroke patients?

作者信息

Kvistad C E, Oeygarden H, Logallo N, Thomassen L, Waje-Andreassen U, Naess H

机构信息

Department of Neurology, Haukeland University Hospital, Bergen, Norway.

出版信息

Acta Neurol Scand. 2014 Nov;130(5):299-304. doi: 10.1111/ane.12225. Epub 2014 Feb 15.

DOI:10.1111/ane.12225
PMID:24527872
Abstract

BACKGROUND

Smoking has been associated with improved outcome in thrombolysed patients with myocardial infarction and higher recanalization rates in stroke patients treated with tissue plasminogen activator (tPA). We hypothesized a positive association between smoking and favourable outcome in stroke patients treated with tPA and no such association in acute stroke patients not treated with tPA, suggesting a beneficial effect of smoking on thrombolysis with tPA.

METHODS

Stroke patients treated with tPA and stroke patients not treated with tPA, but presenting within 6 h after stroke onset, were included in two separate groups. Three groups were defined according to smoking habits: current smoking, previous smoking and no smoking. Functional outcome by modified Rankin Scale (mRS) was assessed after 1 week or at discharge, if discharged earlier. Favourable outcome was defined as mRS 0 or 1.

RESULTS

A total of 399 patients were treated with tPA (94 current smokers, 148 previous smokers and 157 non-smokers), whereas 424 patients were not treated with tPA (90 current smokers, 164 previous smokers and 170 non-smokers). Current smoking was independently associated with favourable outcome in patients treated with tPA when adjusted for confounders (OR 2.08, 95% CI 1.09-3.95, P = 0.025). There was no such association in acute stroke patients not treated with tPA (OR 1.26, 95% CI 0.67-2.36, P = 0.472).

CONCLUSION

Our study showed an association between current smoking and favourable short-term outcome in stroke patients treated with tPA, but not in acute stroke patients not treated with tPA. This may indicate a more effective thrombolysis with tPA in smokers.

摘要

背景

吸烟与心肌梗死溶栓患者预后改善以及组织型纤溶酶原激活剂(tPA)治疗的中风患者再通率升高有关。我们假设吸烟与tPA治疗的中风患者良好预后之间存在正相关,而在未接受tPA治疗的急性中风患者中不存在这种相关性,这表明吸烟对tPA溶栓有有益作用。

方法

接受tPA治疗的中风患者和未接受tPA治疗但在中风发作后6小时内就诊的中风患者被纳入两个独立的组。根据吸烟习惯定义了三组:当前吸烟者、既往吸烟者和不吸烟者。在1周后或更早出院时,采用改良Rankin量表(mRS)评估功能结局。良好结局定义为mRS 0或1。

结果

共有399例患者接受了tPA治疗(94例当前吸烟者,148例既往吸烟者和157例不吸烟者),而424例患者未接受tPA治疗(90例当前吸烟者,164例既往吸烟者和170例不吸烟者)。在调整混杂因素后,当前吸烟与接受tPA治疗的患者的良好结局独立相关(OR 2.08,95%CI 1.09 - 3.95,P = 0.025)。在未接受tPA治疗的急性中风患者中不存在这种相关性(OR 1.26,95%CI 0.67 - 2.36,P = 0.472)。

结论

我们的研究表明,当前吸烟与接受tPA治疗的中风患者的良好短期结局之间存在关联,但在未接受tPA治疗的急性中风患者中不存在这种关联。这可能表明吸烟者使用tPA溶栓更有效。

相似文献

1
Is smoking associated with favourable outcome in tPA-treated stroke patients?吸烟与接受tPA治疗的中风患者的良好预后有关吗?
Acta Neurol Scand. 2014 Nov;130(5):299-304. doi: 10.1111/ane.12225. Epub 2014 Feb 15.
2
Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator.接受组织型纤溶酶原激活物治疗的脑卒中患者的康复结局。
PM R. 2010 Aug;2(8):698-702; quiz 792. doi: 10.1016/j.pmrj.2010.04.029.
3
Safety of off-label stroke treatment with tissue plasminogen activator.组织型纤溶酶原激活剂超说明书治疗脑卒中的安全性。
Acta Neurol Scand. 2013 Jul;128(1):48-53. doi: 10.1111/ane.12076. Epub 2013 Jan 11.
4
Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.提高组织型纤溶酶原激活剂治疗患者再通对卒中结局的预测准确性。
Stroke. 2004 Jan;35(1):151-6. doi: 10.1161/01.STR.0000106485.04500.4A. Epub 2003 Dec 11.
5
Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.病例组合差异对急性脑缺血静脉溶栓后吸烟者更好结局的影响。
Eur Neurol. 2012;67(3):178-83. doi: 10.1159/000334847. Epub 2012 Jan 28.
6
Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.早期再通的益处可持续3个月吗?一项前瞻性队列研究。
Stroke. 2003 Mar;34(3):695-8. doi: 10.1161/01.STR.0000055940.00316.6B. Epub 2003 Feb 13.
7
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.与使用重组组织型纤溶酶原激活剂治疗急性缺血性脑卒中相关的质量调整生命年获益:1998-2011 年。
Int J Stroke. 2016 Feb;11(2):198-205. doi: 10.1177/1747493015609776.
8
Body temperature and major neurological improvement in tPA-treated stroke patients.溶栓治疗的脑卒中患者的体温与主要神经功能改善。
Acta Neurol Scand. 2014 May;129(5):325-9. doi: 10.1111/ane.12184. Epub 2013 Sep 20.
9
A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.急性缺血性脑卒中的新治疗策略:基于 13 例连续患者的初步结果,对近端大脑中动脉闭塞进行序贯联合静脉 tPA-替奈普酶治疗。
Stroke. 2011 Jun;42(6):1644-7. doi: 10.1161/STROKEAHA.110.610147. Epub 2011 Apr 28.
10
Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.在急性缺血性中风患者中,可渗透血栓与静脉注射重组组织型纤溶酶原激活剂治疗成功率较高相关。
Stroke. 2016 Aug;47(8):2058-65. doi: 10.1161/STROKEAHA.116.013306. Epub 2016 Jun 23.

引用本文的文献

1
Evaluation of demographic/clinical features and hemorrhagic complications in patients with ischemic stroke who underwent reperfusion therapy.评估接受再灌注治疗的缺血性脑卒中患者的人口统计学/临床特征和出血性并发症。
Nagoya J Med Sci. 2024 May;86(2):237-251. doi: 10.18999/nagjms.86.2.237.
2
Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke.吸烟状态对急性缺血性中风再灌注治疗后临床结局的影响。
Sci Rep. 2024 Apr 23;14(1):9290. doi: 10.1038/s41598-024-59508-3.
3
Machine learning to predict futile recanalization of large vessel occlusion before and after endovascular thrombectomy.
机器学习预测血管内血栓切除术前后大血管闭塞的无效再通情况。
Front Neurol. 2022 Aug 19;13:909403. doi: 10.3389/fneur.2022.909403. eCollection 2022.
4
Impact of Stroke Severity on the Smoking Paradox in Patients Treated with Intravenous Thrombolysis.卒中严重程度对接受静脉溶栓治疗患者吸烟悖论的影响。
Curr Neurovasc Res. 2022;19(2):203-209. doi: 10.2174/1567202619666220530092614.
5
The smoking paradox in ischemic stroke patients treated with intra-arterial thrombolysis in combination with mechanical thrombectomy-VISTA-Endovascular.血管内治疗联合机械取栓治疗的缺血性脑卒中患者中的吸烟悖论-VISTA-血管内研究。
PLoS One. 2021 May 20;16(5):e0251888. doi: 10.1371/journal.pone.0251888. eCollection 2021.
6
Smoking Does Not Alter Treatment Effect of Intravenous Thrombolysis in Mild to Moderate Acute Ischemic Stroke-A Dutch String-of-Pearls Institute (PSI) Stroke Study.吸烟不改变轻度至中度急性缺血性卒中静脉溶栓的治疗效果——一项荷兰珍珠链研究所(PSI)卒中研究
Front Neurol. 2020 Jul 31;11:786. doi: 10.3389/fneur.2020.00786. eCollection 2020.
7
The association between smoking and unfavorable outcomes in acute ischemic stroke patients with mechanical thrombectomy.急性缺血性脑卒中患者机械取栓术后吸烟与不良预后的相关性
Tob Induc Dis. 2020 Apr 6;18:31. doi: 10.18332/tid/119229. eCollection 2020.
8
Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke.血清免疫球蛋白 G 抗体滴度对核梭杆菌与中风后不良预后相关。
Clin Exp Immunol. 2020 Jun;200(3):302-309. doi: 10.1111/cei.13430. Epub 2020 Mar 24.
9
Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients-A Analysis of the WAKE-UP Trial.当前吸烟状态不影响急性缺血性卒中患者静脉溶栓的治疗效果——来自WAKE-UP试验的分析
Front Neurol. 2019 Nov 22;10:1239. doi: 10.3389/fneur.2019.01239. eCollection 2019.
10
Impact of Comorbidities and Smoking on the Outcome in Aneurysmal Subarachnoid Hemorrhage.合并症和吸烟对动脉瘤性蛛网膜下腔出血结局的影响。
Sci Rep. 2018 Aug 17;8(1):12335. doi: 10.1038/s41598-018-30878-9.